Almalki ZS - Search Results

1

Implementing an Antimicrobial Stewardship Programme to Improve Adherence to a Perioperative Prophylaxis Guideline.

Ahmed NJ, Almalki ZS, Alfaifi AA, Alshehri AM, Alahmari AK, Elazab E, Almansour A, Haseeb A, Balaha MF, Khan AH. Ahmed NJ, et al. Among authors: almalki zs. Healthcare (Basel). 2022 Mar 1;10(3):464. doi: 10.3390/healthcare10030464. Healthcare (Basel). 2022. PMID: 35326942 Free PMC article.

2

Access to orphan drugs in the Middle East: Challenge and perspective.

Almalki ZS, Alahmari AK, Guo JJ, Kelton CM. Almalki ZS, et al. Intractable Rare Dis Res. 2012 Nov;1(4):139-43. doi: 10.5582/irdr.2012.v1.4.139. Intractable Rare Dis Res. 2012. PMID: 25343087 Free PMC article. Review.

3

Off-label use of oral fluoroquinolone antibiotics in outpatient settings in the United States, 2006 to 2012.

Almalki ZS, Alahmari AK, Guo JJ, Cavanaugh TM. Almalki ZS, et al. Pharmacoepidemiol Drug Saf. 2016 Sep;25(9):1042-51. doi: 10.1002/pds.4021. Epub 2016 May 2. Pharmacoepidemiol Drug Saf. 2016. PMID: 27133913

4

Thromboembolic Events Associated with Bevacizumab plus Chemotherapy for Patients with Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials.

Alahmari AK, Almalki ZS, Alahmari AK, Guo JJ. Alahmari AK, et al. Among authors: almalki zs. Am Health Drug Benefits. 2016 Jun;9(4):221-32. Am Health Drug Benefits. 2016. PMID: 27688834 Free PMC article.

5

Cost-Effectiveness of Simvastatin Plus Ezetimibe for Cardiovascular Prevention in Patients With a History of Acute Coronary Syndrome: Analysis of Results of the IMPROVE-IT Trial.

Almalki ZS, Guo JJ, Alahmari A, Alotaibi N, Thaibah H. Almalki ZS, et al. Heart Lung Circ. 2018 Jun;27(6):656-665. doi: 10.1016/j.hlc.2017.05.139. Epub 2017 Jun 15. Heart Lung Circ. 2018. PMID: 28716519 Clinical Trial.

6

Prevalence, risk factors, and management of uncontrolled hypertension among patients with diabetes: A hospital-based cross-sectional study.

Almalki ZS, Albassam AA, Alhejji NS, Alotaibi BS, Al-Oqayli LA, Ahmed NJ. Almalki ZS, et al. Prim Care Diabetes. 2020 Dec;14(6):610-615. doi: 10.1016/j.pcd.2020.02.004. Epub 2020 Feb 27. Prim Care Diabetes. 2020. PMID: 32115377

7

Exploring patient-safety culture in the community pharmacy setting: a national cross-sectional study.

Almalki ZS, Alshehri AM, Alturki LA, Altamimi RA, Albassam AA, Alqurashi MS, Saleh Al-Omaim FA, Ahmed N. Almalki ZS, et al. Postgrad Med. 2021 Jan;133(1):57-65. doi: 10.1080/00325481.2020.1806593. Epub 2020 Sep 23. Postgrad Med. 2021. PMID: 32755512

8

Assessing quality of life using WHOQOL-BREF: A cross-sectional insight among patients on warfarin in Malaysia.

Iqbal MS, Kassab YW, Al-Saikhan FI, Almalki ZS, Haseeb A, Iqbal MZ, Ali M. Iqbal MS, et al. Among authors: almalki zs. Saudi Pharm J. 2020 Aug;28(8):936-942. doi: 10.1016/j.jsps.2020.06.014. Epub 2020 Jun 25. Saudi Pharm J. 2020. PMID: 32792838 Free PMC article.

9

Clinical Characteristics and Outcomes Among COVID-19 Hospitalized Patients with Chronic Conditions: A Retrospective Single-Center Study.

Almalki ZS, Khan MF, Almazrou S, Alanazi AS, Iqbal MS, Alqahtani A, Alghamdi S, Alahmari AK. Almalki ZS, et al. J Multidiscip Healthc. 2020 Oct 6;13:1089-1097. doi: 10.2147/JMDH.S273918. eCollection 2020. J Multidiscip Healthc. 2020. PMID: 33116555 Free PMC article.

10

The potential of drug-herbal interaction among patients with chronic diseases in Saudi Arabia.

Albassam AA, Alanazi A, Alhaqbani N, Alhoti F, Almalki ZS, Alshehri AM, Alzahrani J. Albassam AA, et al. Among authors: almalki zs. Complement Ther Clin Pract. 2021 May;43:101324. doi: 10.1016/j.ctcp.2021.101324. Epub 2021 Feb 2. Complement Ther Clin Pract. 2021. PMID: 33765548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters